1. Chronic aryl hydrocarbon receptor activity impairs muscle mitochondrial function with tobacco smoking
- Author
-
Liam F. Fitzgerald, Jacob Lackey, Ahmad Moussa, Sohan V. Shah, Ana Maria Castellanos, Shawn Khan, Martin Schonk, Trace Thome, Zachary R. Salyers, Nishka Jakkidi, Kyoungrae Kim, Qingping Yang, Russell T. Hepple, and Terence E. Ryan
- Subjects
Atrophy ,Cigarette ,Dioxin ,Skeletal muscle ,Diseases of the musculoskeletal system ,RC925-935 ,Human anatomy ,QM1-695 - Abstract
Abstract Background Accumulating evidence has demonstrated that chronic tobacco smoking directly contributes to skeletal muscle dysfunction independent of its pathological impact to the cardiorespiratory systems. The mechanisms underlying tobacco smoke toxicity in skeletal muscle are not fully resolved. In this study, the role of the aryl hydrocarbon receptor (AHR), a transcription factor known to be activated with tobacco smoke, was investigated. Methods AHR related gene (mRNA) expression was quantified in skeletal muscle from adult controls and patients with chronic obstructive pulmonary disease (COPD), as well as mice with and without cigarette smoke exposure. Utilizing both skeletal muscle‐specific AHR knockout mice exposed to chronic repeated (5 days per week for 16 weeks) cigarette smoke and skeletal muscle‐specific expression of a constitutively active mutant AHR in healthy mice, a battery of assessments interrogating muscle size, contractile function, mitochondrial energetics, and RNA sequencing were employed. Results Skeletal muscle from COPD patients (N = 79, age = 67.0 ± 8.4 years) had higher levels of AHR (P = 0.0451) and CYP1B1 (P
- Published
- 2024
- Full Text
- View/download PDF